Mast cell proliferative disorders: current view on variants recognized by the World Health Organization.
about
Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapyChronic mast cell leukemia: a novel leukemia-variant with distinct morphological and clinical featuresHypotension, Syncope, and Fever in Systemic Mastocytosis without Skin Infiltration and Rapid Response to Corticosteroid and Cyclosporin: A Case Report.Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposalEvidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression.Telangiectasia macularis eruptiva perstans: more than skin deep.Mastocytosis: state of the art.Long-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT.Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia.Systemic mastocytosis: bone marrow pathology, classification, and current therapies.Hematopoietic growth factors, signaling and the chronic myeloproliferative disorders.Neonatal onset diffuse cutaneous mastocytosis: a case report and review of the literature.Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives.European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives.Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology.Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1.Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM)Serum total tryptase level confirms itself as a more reliable marker of mast cells burden in mast cell leukaemia (aleukaemic variant).Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients.Neonatal mastocytosis with pachydermic bullous skin without c-Kit 816 mutation.
P2860
Q21560915-625F2B7B-D79F-489B-A52E-646DAECE0BC0Q27026581-179EC519-A7F1-4AAB-A1B8-A90607C4B6CAQ33159586-775CD782-6B27-48DF-A695-8840190F3250Q34137971-96F8A79C-C584-446E-BECD-6403A4DDB977Q34321423-977A8549-08A3-4CCA-AD32-B2815F3ADDE9Q34413811-12E62106-F907-418A-96B3-3DA891880116Q34641105-53DA2952-F369-468B-98DA-3936015A6504Q35153623-D23E4714-261F-4CAD-A4C8-85AF80B109B7Q35807869-385BF4C2-3455-435E-9B1B-B6E3191A7484Q36182749-4C0FDDA8-5B79-4877-8393-DADA94E1ADC5Q36630747-2385A20C-4E5B-41E1-92E4-6FF75F7A3A0EQ37777178-A30629BE-6055-4259-8666-AF497CCED1E5Q37810130-EC9C916A-08EE-4CAA-A050-0BEC103E3D91Q38062360-2F926012-8C28-4532-B0C6-B983F8FE177AQ39779573-61C244D7-D0DA-4ECF-A58D-C1323BAAE189Q40443526-6945DB02-E458-4676-A3FB-A091F3EBF692Q40582535-CCDDFA8A-1097-48ED-940C-67D11C616B15Q42131722-8B2E57AD-42F8-47EF-B03E-02D9EC7DAE85Q44022417-77D57E2B-50AF-422A-8561-659598C0CEABQ46828964-79B65289-F00F-4043-93EA-6958FE1CF9FF
P2860
Mast cell proliferative disorders: current view on variants recognized by the World Health Organization.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Mast cell proliferative disord ...... the World Health Organization.
@ast
Mast cell proliferative disord ...... the World Health Organization.
@en
type
label
Mast cell proliferative disord ...... the World Health Organization.
@ast
Mast cell proliferative disord ...... the World Health Organization.
@en
prefLabel
Mast cell proliferative disord ...... the World Health Organization.
@ast
Mast cell proliferative disord ...... the World Health Organization.
@en
P2093
P1476
Mast cell proliferative disord ...... the World Health Organization.
@en
P2093
Dean D Metcalfe
Hans-Peter Horny
Peter Valent
Wolfgang R Sperr
P304
P356
10.1016/S0889-8588(03)00089-3
P50
P577
2003-10-01T00:00:00Z